Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2000
10/12/2000CA2367100A1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000CA2367051A1 Use of arylalkanoylpyridazines
10/12/2000CA2366944A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2366895A1 Immunomodulating polymers
10/12/2000CA2366799A1 Propofol compositions containing preservative additives
10/12/2000CA2366791A1 Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second cns stimulant
10/12/2000CA2366264A1 Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/12/2000CA2365970A1 Chemokine-derived synthetic peptides
10/12/2000CA2365548A1 Protein-protein from s. cerevisiae and methods of using same
10/12/2000CA2365526A1 Recombinant influenza viruses for vaccines and gene therapy
10/12/2000CA2365500A1 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000CA2365421A1 Vesicle associated proteins
10/12/2000CA2365397A1 Novel proteins, gene encoding the same and method of utilization thereof
10/12/2000CA2361988A1 Use of tianeptin in the production of medicaments to treat neurodegenerative pathologies
10/12/2000CA2361734A1 Pharmaceutically active compounds and methods of use thereof
10/11/2000EP1043332A1 Dipeptides comprising cyclopentan-beta-amino acids
10/11/2000EP1043327A1 Phosphonocephem derivatives, process for the preparation of the same, and use thereof
10/11/2000EP1043318A1 Salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydial, antiviral and immuno-modulating activity
10/11/2000EP1043316A2 Nitroimidazole derivatives as sensitivity enhancers for chemotherapy and radiotherapy
10/11/2000EP1043029A1 Campylobacter vaccine
10/11/2000EP1042498A1 A method of finding agonist and antagonist to human 11cb splice variant
10/11/2000EP1042492A1 Humanized monoclonal antibodies that protect against shiga toxin induced disease
10/11/2000EP1042482A1 Acetyl-coa-carboxylase from candida albicans
10/11/2000EP1042480A1 Streptococcal heat shock proteins of the hsp60 family
10/11/2000EP1042363A1 Novel anti-hiv immunogens (toxoids), preparation methods and use for preventing and treating aids
10/11/2000EP1042341A1 Nucleoside analog compositions and uses thereof
10/11/2000EP1042340A1 6-o-alkyl erythromycin b oxime
10/11/2000EP1042334A1 Beta-lactamase and dd-peptidase inhibitors
10/11/2000EP1042324A1 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
10/11/2000EP1042323A1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them
10/11/2000EP1042316A1 Indole derivatives useful a.o. for the treatment of osteoporosis
10/11/2000EP1042307A1 Aminothiazole inhibitors of cyclin dependent kinases
10/11/2000EP1042295A1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
10/11/2000EP1042293A1 Substituted pyridine and pyridazine compounds and their pharmaceutical use
10/11/2000EP1042286A1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith
10/11/2000EP1042280A2 Prodrugs of aspartyl protease inhibitors
10/11/2000EP1042003A1 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo
10/11/2000EP1042001A1 Use of microparticles combined with submicron oil-in-water emulsions
10/11/2000EP1041991A1 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
10/11/2000EP1041986A1 Pharmaceutically active compound and methods of use
10/11/2000EP1041983A1 Application of enzyme prodrugs as anti-infective agents
10/11/2000EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/11/2000EP1041978A1 Methods of inactivating bacteria including bacterial spores
10/11/2000EP1041888A1 Anti-retroviral immunogens, preparation and use
10/11/2000CN1269804A CTL epitopes from EBV
10/11/2000CN1269803A 6,9-bridged erythromycin derivatives
10/11/2000CN1269801A Purine acyclonucleosides as antiviral agents
10/11/2000CN1269727A Pharmaceutical compositions containing lyosostaphin alone or in combination with antibiotic for treatment of staphylococcal infections
10/11/2000CN1269725A Product comprising at least double stranded RNA combined with at least an antiviral agent
10/11/2000CN1269723A Maternal immue secretions and their use in treatment and/or prophylaxis of conditions of human body
10/11/2000CN1269245A Static hydraulic process to prepare influenza virus vaccine
10/11/2000CN1269244A Nanometer-level influenza virus splitting process to make subunit vaccine
10/11/2000CN1269230A Chinese medicinal skin disinfectant
10/11/2000CN1269209A Double-layered buccal tablet of Chinese globeflower and vitamin C and its making process
10/11/2000CN1057306C New polypeptide compound and process for preparation thereof
10/11/2000CN1057297C Waterless crystallization of quinolone derivative and crystallization method of its 3/2 hydrate
10/11/2000CN1057231C Modulation of AIDS virus-related events by double-stuanded RNAs
10/10/2000US6130348 Silylation of carbamate group to protect; alkylation with alkyllithium
10/10/2000US6130326 L-ribavirin. oh; anticarcinogenic/antitumor agents; viricides; fungicides; treatment of autoimmune diseases
10/10/2000US6130250 Veterinary use of a pleuromutilin derivative
10/10/2000US6130233 Methods and compositions for treating allergic disorders and other disorders using metabolic derivatives of astemizole
10/10/2000US6130226 Immunotherapeutic agents
10/10/2000US6130091 Method for obtaining a peptide derived from the respiratory syncytial virus polypeptide and bacterium expressing it
10/10/2000US6130087 Methods for generating cytotoxic T cells in vitro
10/10/2000US6130062 Production of proteins in host cells
10/10/2000US6130059 Recombinant polynucleotide of cytotoxin having defined nucleotide sequence
10/10/2000US6129923 Treatment of H. pylori associated gastroduodenal disease
10/10/2000US6129922 Methods for adjuvant free hepatitis A virus vaccination
10/10/2000US6129920 Inactivated infectious bursal disease vaccine
10/10/2000US6129917 Immunogenic compositions comprising porphyromonas gingivalis proteins and/or peptides and methods
10/10/2000CA2183415C A new skin preparation composition
10/10/2000CA2080231C 2'-o-alkylnucleotides as well as polymers which contain such nucleotides
10/10/2000CA2020346C Antibiotic ge 2270 factors a1, a2, a3 and h
10/10/2000CA2002839C Parvovirus capsids
10/09/2000CA2303722A1 Campylobacter vaccine
10/05/2000WO2000058513A1 49 human secreted proteins
10/05/2000WO2000058496A1 50 human secreted proteins
10/05/2000WO2000058495A1 45 human secreted proteins
10/05/2000WO2000058494A1 50 human secreted proteins
10/05/2000WO2000058475A2 Streptococcus pneumoniae antigens
10/05/2000WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
10/05/2000WO2000058468A2 47 human secreted proteins
10/05/2000WO2000058467A1 50 human secreted proteins
10/05/2000WO2000058466A2 Protease resistant flint analogs
10/05/2000WO2000058463A1 Polynucleotide and deduced amino acid sequences from stromal cells
10/05/2000WO2000058444A2 Adaptation of virus to vertebrate cells
10/05/2000WO2000058361A1 Melanocortin receptor ligands
10/05/2000WO2000058355A1 50 human secreted proteins
10/05/2000WO2000058350A1 49 human secreted proteins
10/05/2000WO2000058340A2 50 human secreted proteins
10/05/2000WO2000058339A2 50 human secreted proteins
10/05/2000WO2000058334A1 50 human secreted proteins
10/05/2000WO2000058311A1 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics
10/05/2000WO2000058305A1 Novel compounds
10/05/2000WO2000058302A1 Dihydropyrimidines and their use in the treatment of hepatitis b
10/05/2000WO2000058294A1 Antibacterial agents
10/05/2000WO2000058270A2 Hsv primase inhibitors
10/05/2000WO2000057920A2 Method for expressing proteins
10/05/2000WO2000057917A2 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
10/05/2000WO2000057910A1 Attenuated dengue-4 virus vaccine
1 ... 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 ... 1798